Insights

Strategic Focus Inbiose specializes in Human Milk Oligosaccharides and specialty carbohydrates for infant health, nutrition, cosmetics, and beyond, presenting a targeted sales angle to food, infant formula, and pharma sectors seeking clinically relevant oligosaccharides.

Industrial Scale With a scalable fermentation platform and a track record of rapid development and cost-effective production, Inbiose can offer partners a path from R&D to production, appealing to manufacturers needing reliable supply of HMOs at commercial scales.

Regulatory & Acceleration The company provides regulatory services and process development to compress product timelines, enabling faster go-to-market for new nutrition ingredients, cosmetics actives, or therapeutic nutritional products.

Strategic Partnerships Past collaborations with DuPont Nutrition & Health and EIB funding demonstrate a maturity in forming large-scale partnerships, signaling opportunities for co-development, licensing, or joint ventures in infant nutrition and health-focused segments.

Funding & Growth Signals Softer revenue yet strong funding indicates readiness for partnerships and pilot collaborations; potential buyers or licensors could engage in sponsored development, milestone-based licensing, or supply agreements leveraging Inbiose’s HMOs portfolio.

Inbiose Tech Stack

Inbiose uses 8 technology products and services including Odoo, PostgreSQL, Microsoft Outlook, and more. Explore Inbiose's tech stack below.

  • Odoo
    Content Management System
  • PostgreSQL
    Database
  • Microsoft Outlook
    Email
  • Lightbox
    Javascript Libraries
  • Linux
    Programming Languages
  • Python
    Programming Languages
  • HTTP/3
    Web & Portal Technology
  • Google Analytics
    Web Analytics

Inbiose's Email Address Formats

Inbiose uses at least 1 format(s):
Inbiose Email FormatsExamplePercentage
First.Last@inbiose.comJohn.Doe@inbiose.com
81%
Last@inbiose.comDoe@inbiose.com
10%
First.MiddleLast@inbiose.comJohn.MichaelDoe@inbiose.com
8%
First.Middle@inbiose.comJohn.Michael@inbiose.com
1%

Frequently Asked Questions

What is Inbiose's official website and social media links?

Minus sign iconPlus sign icon
Inbiose's official website is inbiose.com and has social profiles on LinkedInCrunchbase.

What is Inbiose's SIC code NAICS code?

Minus sign iconPlus sign icon
Inbiose's SIC code is 8731 - Commercial Physical and Biological Research NAICS code is 541714 - Research and Development in Biotechnology (except Nanobiotechnology).

How many employees does Inbiose have currently?

Minus sign iconPlus sign icon
As of July 2026, Inbiose has approximately 59 employees across 1 continents, including Europe. Key team members include Chief Executive Officer: D. A.Chief Financial Officer: B. F.Chief Operating Officer: J. S.. Explore Inbiose's employee directory with LeadIQ.

What industry does Inbiose belong to?

Minus sign iconPlus sign icon
Inbiose operates in the Biotechnology Research industry.

What technology does Inbiose use?

Minus sign iconPlus sign icon
Inbiose's tech stack includes OdooPostgreSQLMicrosoft OutlookLightboxLinuxPythonHTTP/3Google Analytics.

What is Inbiose's email format?

Minus sign iconPlus sign icon
Inbiose's email format typically follows the pattern of First.Last@inbiose.com. Find more Inbiose email formats with LeadIQ.

How much funding has Inbiose raised to date?

Minus sign iconPlus sign icon
As of July 2026, Inbiose has raised $18M in funding. The last funding round occurred on Aug 14, 2021 for $18M.

When was Inbiose founded?

Minus sign iconPlus sign icon
Inbiose was founded in 2013.
Inbiose logo

Inbiose

Biotechnology ResearchFlanders, Belgium51-200 Employees

Inbiose is a biotechnology research company based in Zwijnaarde, Belgium, focused on specialty carbohydrates for human health. The company develops and produces human milk oligosaccharides and other specialty carbohydrates, with applications in infant nutrition, specialized nutrition, cosmetics, and related markets. It offers a high-throughput development platform, along with process development, scale-up, and regulatory services to accelerate product development and time to market. The organization employs between 51 and 200 people and maintains a website at inbiose.com. Public financial data indicate modest revenue and external funding, including investment from the European Investment Bank.

Section iconCompany Overview

SIC Code
8731 - Commercial Physical and Biological Research
NAICS Code
541714 - Research and Development in Biotechnology (except Nanobiotechnology)
Founded
2013
Employees
51-200

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Aug 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Section iconFunding & Financials

  • $18M

    Inbiose has raised a total of $18M of funding over 1 rounds. Their latest funding round was raised on Aug 14, 2021 in the amount of $18M.

  • $1M

    Inbiose's revenue is estimated to be in the range of $1M

Ready to create more pipeline?

Get a demo and discover why thousands of SDR and Sales teams trust
LeadIQ to help them build pipeline confidently.

© LeadIQ, Inc. All rights reserved.